back to top
HomeMarketCAG Earnings: Conagra Manufacturers Q1 2025 revenue misses estimates; gross sales down...

CAG Earnings: Conagra Manufacturers Q1 2025 revenue misses estimates; gross sales down 3.8% | AlphaStreet

-

Conagra Manufacturers, Inc. (NYSE: CAG), a number one supplier of client packaged items, reported a decline in adjusted earnings for the primary quarter of 2025, reflecting a lower in gross sales.

Web gross sales dropped 3.8% year-over-year to $2.79 billion within the August quarter. The highest line additionally fell in need of Wall Road’s expectations. Natural web gross sales declined 3.5%, harm by the destructive impression of unfavorable worth/combine because of the firm’s strategic investments.

Web earnings, adjusted for particular objects, dropped to $0.53 per share in Q1 from $0.66 per share within the year-ago quarter. On an unadjusted foundation, the corporate reported web earnings of $466.8 million or $0.97 per share within the first quarter, in comparison with $319.7 million or $0.67 per share in the identical interval of 2024.

Prio Efficiency

LEAVE A REPLY

Please enter your comment!
Please enter your name here

CAPTCHA


LATEST POSTS

Ethereum Seems To Reclaim All-time Excessive, Present Cycle To Outperform Previous Cycles? | Bitcoinist.com

Contemplating the continued cycle remains to be within the bull section, confidence in Ethereum about an impending important rally to unprecedented ranges has emerged inside...

ONIX Alternate Expands Globally to Create an Excellent Crypto Buying and selling Platform – Blockchain Information Web site

ONIX Alternate is driving a transformative wave within the cryptocurrency business, redefining world buying and selling platform requirements with cutting-edge expertise and user-focused design ideas....

Bitcoin vs. Ethereum: Will ETH’s January rally put BTC within the shadows once more?

Ethereum has pulled large liquidity from Bitcoin this January, positioning itself for one more sturdy efficiency. With greater stakes than ever, ETH is on observe to...

Cytek Biosciences inventory jumps on new $50M buyback plan By Investing.com

Investing.com -- On Monday, shares of Cytek Biosciences skilled a notable uptick, climbing as excessive as 6.9% throughout intraday buying and selling after the corporate...

Most Popular